Ibm Retirement Fund Novo Cure LTD Transaction History

Ibm Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$75.08 - $121.99 $217,656 - $353,649	-2,899 Closed	0 $0
Q2 2021 Jul 12, 2021	SELL	$130.4 - $225.58 $70,546 - $122,038	-541 Reduced 15.73%	2,899 $643,000
Q1 2021 Apr 22, 2021	SELL	$124.11 - $190.17 $29,786 - $45,640	-240 Reduced 6.52%	3,440 $455,000
Q4 2020 Jan 25, 2021	BUY	$112.16 - $174.14 $50,584 - $78,537	451 Added 13.97%	3,680 $637,000
Q3 2020 Oct 16, 2020	BUY	$58.05 - $111.31 $187,443 - $359,419	3,229 New	3,229 $359,000

266

78.7M

751K

293K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.7B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.